Pirespa pirfenidone regulatory update

InterMune submitted an MAA to the European Medicines Agency (EMA) for pirfenidone to treat idiopathic pulmonary fibrosis (IPF). FDA's Pulmonary-Allergy Drug Advisory Committee will meet on March 9 to ...